← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2004Last known activity
Sep 1, 2015
Acquired by Johnson and Johnson on Jan 1, 2010
Timeline
2000s
- Jan 1, 2000
Crucell— Founded
- Jan 1, 2000
Introgene— Acquired
- Jan 1, 2000
U-Bisys— Acquired
- Jan 1, 2004
ChromaGenics— Acquired
- Jan 1, 2005
Swiss Serum Institute— Acquired
2010s
- Jan 1, 2010
Johnson and Johnson— Acquired By
Drugs by trial phase (28 distinct, 43 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (14 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Subsidiaries (4 direct, 4 total across the full acquisition tree)
Recent trials (50)
- NCT02561871Study directorPhase 1Sep 1, 2015
- NCT02543268Study directorPhase 3Sep 1, 2015
- NCT02543268Lead sponsorPhase 3Sep 1, 2015
- NCT02561871Lead sponsorPhase 1Sep 1, 2015
- NCT02440035Lead sponsorPhase 1Apr 1, 2015
- NCT02376400Lead sponsorPhase 1Apr 1, 2015
- NCT02376400Study directorPhase 1Apr 1, 2015
- NCT02440035Study directorPhase 1Apr 1, 2015
- NCT02376426Study directorPhase 1Mar 1, 2015
- NCT02376426Lead sponsorPhase 1Mar 1, 2015
- NCT02315703Lead sponsorPhase 2Dec 22, 2014
- NCT02315703Study directorPhase 2Dec 22, 2014
- NCT02313077Study directorPhase 1Dec 17, 2014
- NCT02313077Lead sponsorPhase 1Dec 17, 2014
- NCT02304185Lead sponsorPhase 1Dec 1, 2014
Details
- Founded
- Leiden, NL Jan 1, 2000
- Last known activity
- Sep 1, 2015